Efficacy of a Commercial PCV2a Vaccine with a Two-Dose Regimen Against PCV2d

Volume: 6, Issue: 3, Pages: 61 - 61
Published: Jun 28, 2019
Abstract
Porcine circovirus type 2, the causative agent of porcine circovirus associated diseases (PCVAD), consists of three major genotypes PCV2a, 2b and 2d. Current commercial vaccines contain the first-identified PCV2a’s capsid protein or whole virions. Outbreaks of PCVAD, caused by the recently identified PCV2d in vaccinated herds have raised concerns regarding the efficacy of current PCV2a vaccines against PCV2d. Thus, the primary objective of this...
Paper Details
Title
Efficacy of a Commercial PCV2a Vaccine with a Two-Dose Regimen Against PCV2d
Published Date
Jun 28, 2019
Volume
6
Issue
3
Pages
61 - 61
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.